Clarithromycin Oral Suspension 125 mg – Macrolide Antibiotic for Broad-Spectrum Bacterial Infections.
ALCLAR 125: The Composition of Clarithromycin Oral 125 mg is a second-generation macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It shows high efficacy against both typical and atypical pathogens. Its excellent tissue penetration and prolonged half-life ensure sustained antibacterial activity. The oral and injectable forms allow use in a broad spectrum of outpatient and inpatient scenarios, including gastrointestinal infections when combined with PPIs and amoxicillin.
Recommended By Specialists:
✅General Physicians: It is preferred to treat the disease associated with respiratory tract infections, skin & soft tissue infections
✅Pulmonologists_ It is prefer to treat the disease associated with bronchitis, pneumonia, and atypical respiratory infections
✅Gastroenterologists –It is preferred to treat the disease associated with triple therapy for H. pylori infection
Key benefits of Clarithromycin Oral Suspension 125 mg – ALCLAR 125:
✅Broad-Spectrum Antibacterial Action – Effective against respiratory, skin, and soft tissue infections caused by Streptococcus, Staphylococcus, Mycoplasma, H. pylori, and atypical pathogens.
✅Dual Formulations for Versatile Use – Available in suspension for pediatrics, oral tablets for outpatients, and injection for severe systemic infections — ensuring complete flexibility.
✅H. pylori Eradication in GI Use – A key component in triple therapy for H. pylori eradication, improving peptic ulcer healing rates
INDICATIONS:
✅Upper & Lower Respiratory Tract Infections
✅Community-Acquired Pneumonia
✅Acute Otitis Media
✅Skin & Soft Tissue Infections
✅H. pylori Eradication (as part of triple therapy